Solid Biosciences Inc. (SLDB) Financials

SLDB Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 420.6 million 46.5 million
March 31, 2026 422.9 million 48.8 million
Dec. 31, 2025 232.5 million 52.5 million
Sept. 30, 2025 273.9 million 56.0 million

SLDB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -52.7 million 5.6 million
March 31, 2026 -47.4 million 5.2 million
Dec. 31, 2025 -54.1 million 6.5 million
Sept. 30, 2025 -33.6 million 3.9 million

SLDB Net Income

No data available :(

SLDB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 377.7 million - 20.2 million
March 31, 2026 381.3 million - 20.7 million
Dec. 31, 2025 187.9 million - 21.2 million
Sept. 30, 2025 236.1 million - 21.9 million

SLDB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 143.7 million
March 31, 2026 109.8 million
Dec. 31, 2025 94.7 million
Sept. 30, 2025 94.4 million

SLDB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 150000 44.3 million 13.1 million -
March 31, 2026 165000 46.1 million 11.2 million -
Dec. 31, 2025 565000 38.1 million 11.3 million -
Sept. 30, 2025 85000 38.9 million 9.2 million -

SLDB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 395000
Dec. 31, 2025 - 467000
Sept. 30, 2025 - 376000

SLDB

Price: $5.53

52 week price:
3.79
11.45

Earnings Per Share: -1.87 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 27300

Market Capitalization: 674.4 million

Links: